Marker Therapeutics Inc. – Filings and Transcripts

NASDAQ: MRKR
Share price (3/27/26): $1.30
Market cap (3/27/26): $21.7 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus with selling stockholder info

Prospectus supplement

Shelf registration

Exempt offering of securities

Prospectus supplement

Ownership Filter

Knobil Katharine

Eansor Norman David

New Enterprise Associates 16, L.P.

Alyeska Investment Group, L.P.

News Filter

Reports Year-End 2025 Corporate and Financial Results

Shareholder Nominations, Financial Statements or Exhibits

Reports Third Quarter 2025 Financial Results and Provides Business Updates

Appoints Kathryn Penkus Corzo to Board of Directors

Announces First Patient Treated in Off-The-Shelf Program

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC